Etoricoxib not checked
Laboratorios Silanes S.A. de C.V.
FollowEvery change as it happens, and a Monday email
Trials
2 active
6 in total · 1 in the EU
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Gout Arthritis, Gout Attack
- Main trialPhase 3
- “Phase III longitudinal, multicenter, randomized, double-blind clinical trial. The aim of this study is to evaluate the efficacy and safety of the Fixed-Dose Combination of Etoricoxib/Betamethasone Versus Etoricoxib in Patients With Acute Gouty Arthritis”In the company’s words, NCT06863701 on ClinicalTrials.gov
- Other names
- Etori + Tiza · Etori · Etori + Cyano · Etori + Beta · E/T
Other drugs for Gout Arthritis
- DapansutrileOlatec Therapeutics, Inc. · Phase 2/3
- AR882Arthrosi Therapeutics · Phase 2
- SSGJ-6133SBio · Phase 2
Coming up1
- 31 DecPhase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials6
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | 31 Dec 2026 | Efficacy Anda Safety of Etoricoxib With Betamethasone for the Treatment of Acute Gout Arthritis | |
| Phase 3Completed | 15 Mar 2022 | Efficacy and Safety of Fixed-dose Combination of Etoricoxib/Tramadol vs Acetaminophen/Tramadol for Acute Low Back Pain | |
| Phase 3Completed | 4 Oct 2024 | Efficacy and Safety of Etoricoxib/Cyanocobalamin Versus Etoricoxib for Acute Low Back Pain | |
| Phase 3Completed | 20 Aug 2025 | Efficacy and Safety of Etoricoxib/Betamethasone Combination in Acute Bursitis, Tendinitis and Synovitis | |
| Phase 3Completed | 26 Sep 2025 | Efficacy and Safety of Etoricoxib/Tizanidine Versus Etoricoxib for Acute Low Back Pain Associated to Muscle Spasm | |
| Phase 4Authorised | not given | Comparison of the preventive painkiller effect of etoricoxib and celecoxib after M3M surgery: A randomized, double-masked clinical trial |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026